Fuan Pharmaceutical (300194.SZ): Metformin and Empagliflozin Tablets Obtain Drug Registration Certificate.

Announcement from Fuan Pharmaceutical (300194.SZ): The company's wholly-owned subsidiary Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. (referred to as "Qingyutang") recently received a drug registration certificate issued by the National Medical Products Administration. The related drug name is: Metformin Engelejing Tablets. The announcement states that Metformin Engelejing Tablets are indicated for: This product, in combination with diet control and exercise, is suitable for adult patients with type 2 diabetes who are being treated with Engelejing and metformin hydrochloride, to improve blood sugar control in these patients.